Several interventional studies evaluated the effects of drugs used in patients with MetS and T2-DM, namely insulin sensitizers and antidiabetic drugs, on testosterone levels and hypogonadism, and confirmed a strict relationship between obesity and hypogonadism. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.